CompletedNot Applicable

SC2i VIPER: EnVenomation Investigation Pilot to Evaluate Recovery

United States15 participantsStarted 2017-05-05

Plain-language summary

The purpose of this study is to pilot data for a systematic molecular characterization of pathophysiologic perturbations incurred by snake envenomation and compare this to other inflammatory physiologic states such as trauma and sepsis. This sub-study will analyze samples of participants enrolled under the parent study "Surgical Critical Care Initiative Tissue and Data Acquisition Protocol".

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients enrolled into the Surgical Critical Care Initiative Tissue and Data Acquisition Protocol (NCT02182180) who have suffered a snakebite envenomation (enrolled under "Group 5: Non-traumatic conditions: individuals with non-traumatic causes of organ or system failure that mirror the phenotype of traumatic complications in Group 1") are eligible to be included in this study. * Adult patients (18 years of age or older) in a manner that is sensitive to the inclusion of women and members of underserved minority groups. * Potential participants or legally authorized representative (LAR) will be originally identified by clinical team, as described under Pro00054947 (NCT02182180). Only participants enrolled in Pro00054947 (NCT02182180) will be recruited for this sub-study Exclusion Criteria: * Pregnant women will be excluded from the study.

What they're measuring

Survey and Data

Timeframe: 30 days after initial bite for the survey

Trial details

NCT IDNCT03170297

SponsorHenry M. Jackson Foundation for the Advancement of Military Medicine

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-12-15

View on ClinicalTrials.gov More Critical Illness trials